Market openNon-fractional
Silk Road Medical/SILK
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Silk Road Medical
Silk Road Medical Inc is a medical device company focused on reducing the risk of stroke and its devastating impact. The company has a new approach for the treatment of carotid artery disease called transcarotid artery revascularization, or TCAR, which it seeks to establish as the standard of care. TCAR relies on two novel concepts - minimally-invasive direct carotid access in the neck and high-rate blood flow reversal during the procedure to protect the brain - and combines novel endovascular techniques with fundamental surgical principles. TCAR using its portfolio of products has been clinically demonstrated to reduce the upfront morbidity and mortality risks commonly associated with carotid endarterectomy. The company generates all of its revenue in the United States.
Ticker
SILK
Sector
Healthcare
Trading on
NASDAQ
Industry
Health Care Equipment and Supplies
Headquarters
Sunnyvale, United States
Employees
474
Website
silkroadmed.com
SILK Metrics
BasicAdvanced
$1.1B
Market cap
-
P/E ratio
-$1.37
EPS
1.44
Beta
-
Dividend rate
Price and volume
Market cap
$1.1B
Beta
1.44
Financial strength
Current ratio
11.046
Quick ratio
9.451
Long term debt to equity
56.823
Total debt to equity
56.823
Interest coverage (TTM)
-8.30%
Management effectiveness
Return on assets (TTM)
-13.99%
Return on equity (TTM)
-35.04%
Valuation
Price to revenue (TTM)
5.675
Price to book
7.18
Price to tangible book (TTM)
7.18
Price to free cash flow (TTM)
-28.607
Growth
Revenue change (TTM)
23.04%
Earnings per share change (TTM)
-8.34%
3-year revenue growth
33.28%
3-year earnings per share growth
-1.35%
What the Analysts think about SILK
Analyst Ratings
Majority rating from 10 analysts.
SILK Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$48M
2.54%
Net income
-$14M
8.46%
Profit margin
-29.13%
5.77%
SILK Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.35
-$0.33
-$0.33
-$0.36
-
Expected
-$0.39
-$0.35
-$0.42
-$0.40
-$0.38
Surprise
-10.23%
-6.40%
-21.66%
-10.56%
-
SILK News
AllArticlesVideos
![SILK Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Silk Road Medical to Boston Scientific](https://cdn.snapi.dev/images/v1/c/p/press11-2492811.jpg)
SILK Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Silk Road Medical to Boston Scientific
GlobeNewsWire·2 weeks ago
![SILK ROAD MEDICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Silk Road Medical, Inc. - SILK](https://cdn.snapi.dev/images/v1/p/q/press6-2487158.jpg)
SILK ROAD MEDICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Silk Road Medical, Inc. - SILK
Business Wire·2 weeks ago
![ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Silk Road Medical, Inc.](https://cdn.snapi.dev/images/v1/7/e/press4-2485221.jpg)
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Silk Road Medical, Inc.
PRNewsWire·2 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market openNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Silk Road Medical stock?
Silk Road Medical (SILK) has a market cap of $1.1B as of July 05, 2024.
What is the P/E ratio for Silk Road Medical stock?
The price to earnings (P/E) ratio for Silk Road Medical (SILK) stock is 0 as of July 05, 2024.
Does Silk Road Medical stock pay dividends?
No, Silk Road Medical (SILK) stock does not pay dividends to its shareholders as of July 05, 2024.
When is the next Silk Road Medical dividend payment date?
Silk Road Medical (SILK) stock does not pay dividends to its shareholders.
What is the beta indicator for Silk Road Medical?
Silk Road Medical (SILK) has a beta rating of 1.44. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
![Buy or sell Silk Road Medical stock](/_next/image?url=%2Fresources%2Fimages%2Fpromo_phone.png&w=256&q=75)
Buy or sell Silk Road Medical stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.